Technophage featured in ‘The Business Year Portugal 2022’

Technophage featured in ‘The Business Year Portugal 2022’

25 Nov 2022 | News

This year Technophage has been featured in the Portuguese edition of The Business Year. The publication was based on more than 130 face-to-face interviews with leading #investors, business leaders, and government representatives from all the key sectors driving...
Technophage is hiring a Financial Controller

Technophage is hiring a Financial Controller

23 Nov 2022 | Careers

TechnoPhage is currently looking for a new Financial Controller with a degree in Economics, Finance or related area, and at least 7 years of experience in similar roles. Good English language understanding, speaking and writing is essential. Click here to know more...
TechnoPhage S.A. announces spin-off of T-Oncology AG

TechnoPhage S.A. announces spin-off of T-Oncology AG

23 Set 2022 | Press release

TechnoPhage announced the spin-off of T-Oncology AG, which will focus on the development of Antibody Drug Conjugates (ADCs), based on the proprietary Small Domain Antibodies platform (TechnoBodies), for the treatment of cancer. TechnoBodies technology has been...
Technophage granted with the ‘COTEC Innovative Status 2022′

Technophage granted with the ‘COTEC Innovative Status 2022′

1 Ago 2022 | News

Technophage is proud to announce that it has recently been granted with the ‘COTEC Innovative Status 2022’. COTEC Portugal is the main Portuguese business association for the promotion of business innovation and technological cooperation. The COTEC Innovative Status...